18-57697620-A-G

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001374385.1(ATP8B1):​c.696T>C​(p.Asp232Asp) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.999 in 1,613,916 control chromosomes in the GnomAD database, including 805,295 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.99 ( 75238 hom., cov: 29)
Exomes 𝑓: 1.0 ( 730057 hom. )

Consequence

ATP8B1
NM_001374385.1 splice_region, synonymous

Scores

2
Splicing: ADA: 0.00002227
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.0390

Publications

25 publications found
Variant links:
Genes affected
ATP8B1 (HGNC:3706): (ATPase phospholipid transporting 8B1) This gene encodes a member of the P-type cation transport ATPase family, which belongs to the subfamily of aminophospholipid-transporting ATPases. The aminophospholipid translocases transport phosphatidylserine and phosphatidylethanolamine from one side of a bilayer to another. Mutations in this gene may result in progressive familial intrahepatic cholestasis type 1 and in benign recurrent intrahepatic cholestasis. [provided by RefSeq, Jul 2008]
ATP8B1-AS1 (HGNC:56042): (ATP8B1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 18-57697620-A-G is Benign according to our data. Variant chr18-57697620-A-G is described in ClinVar as [Benign]. Clinvar id is 259826.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.039 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.994 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP8B1NM_001374385.1 linkc.696T>C p.Asp232Asp splice_region_variant, synonymous_variant Exon 8 of 28 ENST00000648908.2 NP_001361314.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP8B1ENST00000648908.2 linkc.696T>C p.Asp232Asp splice_region_variant, synonymous_variant Exon 8 of 28 NM_001374385.1 ENSP00000497896.1 O43520

Frequencies

GnomAD3 genomes
AF:
0.994
AC:
151182
AN:
152032
Hom.:
75182
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.981
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.998
Gnomad ASJ
AF:
1.00
Gnomad EAS
AF:
1.00
Gnomad SAS
AF:
1.00
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
1.00
Gnomad NFE
AF:
1.00
Gnomad OTH
AF:
0.996
GnomAD2 exomes
AF:
0.998
AC:
250904
AN:
251298
AF XY:
0.999
show subpopulations
Gnomad AFR exome
AF:
0.980
Gnomad AMR exome
AF:
0.999
Gnomad ASJ exome
AF:
1.00
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.999
GnomAD4 exome
AF:
0.999
AC:
1460930
AN:
1461766
Hom.:
730057
Cov.:
47
AF XY:
0.999
AC XY:
726823
AN XY:
727192
show subpopulations
African (AFR)
AF:
0.981
AC:
32836
AN:
33478
American (AMR)
AF:
0.999
AC:
44677
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
26131
AN:
26136
East Asian (EAS)
AF:
1.00
AC:
39689
AN:
39700
South Asian (SAS)
AF:
1.00
AC:
86252
AN:
86256
European-Finnish (FIN)
AF:
1.00
AC:
53395
AN:
53400
Middle Eastern (MID)
AF:
1.00
AC:
5767
AN:
5768
European-Non Finnish (NFE)
AF:
1.00
AC:
1111862
AN:
1111912
Other (OTH)
AF:
0.999
AC:
60321
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
48
96
145
193
241
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21668
43336
65004
86672
108340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.994
AC:
151297
AN:
152150
Hom.:
75238
Cov.:
29
AF XY:
0.995
AC XY:
73997
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.981
AC:
40691
AN:
41490
American (AMR)
AF:
0.998
AC:
15252
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
1.00
AC:
3471
AN:
3472
East Asian (EAS)
AF:
1.00
AC:
5156
AN:
5158
South Asian (SAS)
AF:
1.00
AC:
4791
AN:
4792
European-Finnish (FIN)
AF:
1.00
AC:
10618
AN:
10618
Middle Eastern (MID)
AF:
1.00
AC:
294
AN:
294
European-Non Finnish (NFE)
AF:
1.00
AC:
68006
AN:
68012
Other (OTH)
AF:
0.996
AC:
2106
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
42
84
127
169
211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.998
Hom.:
103586
Bravo
AF:
0.994
Asia WGS
AF:
0.999
AC:
3475
AN:
3478
EpiCase
AF:
1.00
EpiControl
AF:
1.00

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 02, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 28, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Progressive familial intrahepatic cholestasis type 1 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cholestasis, intrahepatic, of pregnancy, 1 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.38
CADD
Benign
0.78
DANN
Benign
0.80
PhyloP100
-0.039
Mutation Taster
=81/19
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000022
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs319438; hg19: chr18-55364852; API